Skip to main content

Table 1 Baseline characteristics and comparisons between men and women for 284 persons with T1D

From: Abdominal obesity in type 1 diabetes associated with gender, cardiovascular risk factors and complications, and difficulties achieving treatment targets: a cross sectional study at a secondary care diabetes clinic

 

All patients

Men

Women

P a

N

284

159 (56)

125 (44)

 

Age (years)

42 (32, 51; 18–59)

43 (32, 52)

41 (30, 50)

0.12 b

Diabetes duration (years)

20 (11, 30; 1–55)

21 (11–32)

19 (11, 29)

0.26 b

WC (meters)

–

0.88 (0.82, 0.95; 0.65–1.33)

0.79 (0.75, 0.90; 0.63–1.25)

–

Abdominal obesity c

49 (17)

13 (8)

36 (29)

< 0.001

General obesity d

34 (12)

11 (7)

23 (18)

0.005

HbA1c > 52 mmol/mol (>  6.9%)

230 (81)

130 (82)

100 (80)

0.76

HbA1c > 70 mmol/mol (>  8.6%)

39 (24)

39 (24)

39 (31)

0.23

TC (mmol/l)

4.6 (4.1, 5.2; 2.1–10.9)

4.5 (4.0, 5.1)

4.7 (4.1, 5.4)

0.069 b

High TC (> 4.5 mmol/l)

149 (52)

78 (49)

71 (57)

0.23

LDL (mmol/l)

2.8 (2.4, 3.3; 0.6–8.3)

2.8 (2.4, 3.3)

2.9 (2.4, 3.4)

0.51 b

High LDL (> 2.5 mmol/l)

182 (64)

102 (64)

80 (64)

> 0.99

Triglycerides (mmol/l)

0.9 (0.7, 1.3; 0.6–5.9)

0.9 (0.7, 1.3)

0.8 (0.6, 1.3)

0.47 b

High triglycerides (≥ 1.7 mmol/l)

34 (12)

16 (10)

18 (14)

0.28

HDL (mmol/l)

1.5 (1.3, 1.8; 0.8–2.7)

1.4 (1.2, 1.7)

1.6 (1.4, 1.8)

0.002 b

Low HDL (M/W: < 1.04/< 1.29 mmol/l/)

32 (11)

17 (11)

15 (12)

0.85

Hs-CRP e (mg/l)

0.6 (0.3, 1.7; 0.03–8.9)

0.5 (0.2, 1.4)

0.9 (0.4, 2.5)

0.008 b

SBP f (mm Hg)

120 (111, 130; 100–160)

125 (120, 130)

120 (110, 130)

< 0.001 b

High SBP f (> 130 mmHg)

100 (35)

67 (42)

33 (26)

0.006

DBP h (mm Hg)

70 (70, 75; 55–100)

70 (70, 80)

70 (65, 75)

< 0.001 b

High DBP g (>  80 mmHg)

13 (5)

10 (6)

3 (2)

0.16

Hypoglycemia (severe episodes)

13 (5%)

7 (4)

6 (5)

> 0.99

Smoking h

28 (10)

18 (12)

10 (8)

0.42

Physical inactivity h (<  1/week)

31 (11)

18 (12)

13 (11)

0.85

CV i complications

10 (4)

6 (4)

4 (3)

> 0.99

LLD j

133 (47)

77 (48)

56 (45)

0.55

AHD k

95 (34)

61 (38)

34 (27)

0.057

MDII l and OAD m

17 (6)

6 (4)

11 (9)

0.15

CSII n

26 (9)

13 (8)

13 (10)

MDII l

241 (85)

140 (88)

101 (81)

Reached all treatment targets o

19 (7)

11 (7)

8 (6)

> 0.99

  1. Data are n (%) or median (q1, q3; min-max)
  2. a Fisher’s exact test unless otherwise indicated. b Mann-Whitney U test. c WC: men/women ≥1.02/≥0.88 m. d BMI ≥30 kg/m2. e N = 171, missing values for men/women: n = 54/59. f Systolic blood pressure. g Diastolic blood pressure. h Missing values men/women: n = 6/6. i Cardiovascular. j Lipid-lowering drugs. k Anti-hypertensive drugs. l Multiple daily insulin injections. m Oral antidiabetic drugs. n Continuous subcutaneous insulin infusion. o Blood pressure ≤ 130/≤ 80, TC ≤ 4.5, LDL ≤ 2.5 and HbA1c ≤ 52
Back to article page

BMC Obesity

ISSN: 2052-9538

Contact us